FI902725A0 - Menetelmä terapeuttisesti käyttökelpoisten (7-okso-2,4-ditia-1-atsabisyklo/3,2,0/hept-3-yleenietikkahappojohdannaisten valmistamiseksi - Google Patents
Menetelmä terapeuttisesti käyttökelpoisten (7-okso-2,4-ditia-1-atsabisyklo/3,2,0/hept-3-yleenietikkahappojohdannaisten valmistamiseksiInfo
- Publication number
- FI902725A0 FI902725A0 FI902725A FI902725A FI902725A0 FI 902725 A0 FI902725 A0 FI 902725A0 FI 902725 A FI902725 A FI 902725A FI 902725 A FI902725 A FI 902725A FI 902725 A0 FI902725 A0 FI 902725A0
- Authority
- FI
- Finland
- Prior art keywords
- lower alkyl
- compounds
- sec
- oxycarbonyl
- dithia
- Prior art date
Links
- 150000001242 acetic acid derivatives Chemical class 0.000 title 1
- 125000000217 alkyl group Chemical group 0.000 abstract 8
- 150000001875 compounds Chemical class 0.000 abstract 3
- 229910052739 hydrogen Inorganic materials 0.000 abstract 3
- 239000001257 hydrogen Substances 0.000 abstract 3
- 125000005740 oxycarbonyl group Chemical group [*:1]OC([*:2])=O 0.000 abstract 3
- 150000002431 hydrogen Chemical class 0.000 abstract 2
- 125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 abstract 2
- 206010001052 Acute respiratory distress syndrome Diseases 0.000 abstract 1
- UFHFLCQGNIYNRP-UHFFFAOYSA-N Hydrogen Chemical compound [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 abstract 1
- 102000016387 Pancreatic elastase Human genes 0.000 abstract 1
- 108010067372 Pancreatic elastase Proteins 0.000 abstract 1
- 208000013616 Respiratory Distress Syndrome Diseases 0.000 abstract 1
- 208000011341 adult acute respiratory distress syndrome Diseases 0.000 abstract 1
- 201000000028 adult respiratory distress syndrome Diseases 0.000 abstract 1
- 125000003342 alkenyl group Chemical group 0.000 abstract 1
- 229940121363 anti-inflammatory agent Drugs 0.000 abstract 1
- 239000002260 anti-inflammatory agent Substances 0.000 abstract 1
- -1 beta lactam compounds Chemical class 0.000 abstract 1
- 230000000694 effects Effects 0.000 abstract 1
- 230000005764 inhibitory process Effects 0.000 abstract 1
- 230000003389 potentiating effect Effects 0.000 abstract 1
- 206010039073 rheumatoid arthritis Diseases 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D513/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00
- C07D513/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00 in which the condensed system contains two hetero rings
- C07D513/04—Ortho-condensed systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/16—Central respiratory analeptics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D499/00—Heterocyclic compounds containing 4-thia-1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula:, e.g. penicillins, penems; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring
- C07D499/88—Compounds with a double bond between positions 2 and 3 and a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, e.g. an ester or nitrile radical, directly attached in position 2
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pulmonology (AREA)
- Pain & Pain Management (AREA)
- Rheumatology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Hydrogenated Pyridines (AREA)
- Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Enzymes And Modification Thereof (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US35954889 | 1989-06-01 | ||
| US07/359,548 US5132300A (en) | 1989-06-01 | 1989-06-01 | Beta-lactam elastase inhibitors |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| FI902725A0 true FI902725A0 (fi) | 1990-06-01 |
| FI96314B FI96314B (fi) | 1996-02-29 |
| FI96314C FI96314C (fi) | 1996-06-10 |
Family
ID=23414295
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| FI902725A FI96314C (fi) | 1989-06-01 | 1990-06-01 | Menetelmä terapeuttisesti käyttökelpoisten (7-okso-2,4-ditia-1-atsabisyklo/3,2,0/hept-3-yleenietikkahappojohdannaisten valmistamiseksi |
Country Status (11)
| Country | Link |
|---|---|
| US (1) | US5132300A (fi) |
| EP (1) | EP0401049B1 (fi) |
| JP (1) | JPH0780891B2 (fi) |
| AT (1) | ATE110388T1 (fi) |
| CA (1) | CA2017920C (fi) |
| DE (1) | DE69011747T2 (fi) |
| DK (1) | DK0401049T3 (fi) |
| ES (1) | ES2060042T3 (fi) |
| FI (1) | FI96314C (fi) |
| IE (1) | IE64767B1 (fi) |
| PT (1) | PT94243B (fi) |
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| TW383308B (en) * | 1993-08-24 | 2000-03-01 | Hoffmann La Roche | 2-beta-alkenyl penam sulfones as beta-lactamase inhibitors |
| US5474993A (en) * | 1994-06-14 | 1995-12-12 | Sterling Winthrop, Inc. | Lactam inhibitors of cholesterol esterase |
| US7504228B2 (en) * | 2001-06-05 | 2009-03-17 | Qlt Inc. | Integrin linked kinase modulation of monocyte activation |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4493839A (en) * | 1982-05-24 | 1985-01-15 | Merck & Co., Inc. | 1-Carbapenem-3-carboxylic esters as anti-inflammatory agents |
| US4797396A (en) * | 1984-07-02 | 1989-01-10 | Merck & Co., Inc. | β-Lactam derivatives as anti-inflammatory and antidegenerative agents |
| US4847247A (en) * | 1984-07-30 | 1989-07-11 | Merck & Co., Inc. | Penicillin derivatives as anti-inflammatory and antidegenerative agents |
| EP0265117B1 (en) * | 1986-10-16 | 1992-06-17 | Merck & Co. Inc. | 2-substituted alkyl carbapenem antibacterials |
-
1989
- 1989-06-01 US US07/359,548 patent/US5132300A/en not_active Expired - Lifetime
-
1990
- 1990-05-30 CA CA002017920A patent/CA2017920C/en not_active Expired - Fee Related
- 1990-06-01 DE DE69011747T patent/DE69011747T2/de not_active Expired - Fee Related
- 1990-06-01 PT PT94243A patent/PT94243B/pt not_active IP Right Cessation
- 1990-06-01 IE IE196490A patent/IE64767B1/en not_active IP Right Cessation
- 1990-06-01 AT AT90306030T patent/ATE110388T1/de not_active IP Right Cessation
- 1990-06-01 DK DK90306030.9T patent/DK0401049T3/da active
- 1990-06-01 ES ES90306030T patent/ES2060042T3/es not_active Expired - Lifetime
- 1990-06-01 JP JP2145259A patent/JPH0780891B2/ja not_active Expired - Fee Related
- 1990-06-01 EP EP90306030A patent/EP0401049B1/en not_active Expired - Lifetime
- 1990-06-01 FI FI902725A patent/FI96314C/fi active IP Right Grant
Also Published As
| Publication number | Publication date |
|---|---|
| DE69011747T2 (de) | 1994-12-22 |
| FI96314C (fi) | 1996-06-10 |
| JPH0780891B2 (ja) | 1995-08-30 |
| IE901964L (en) | 1990-12-01 |
| IE64767B1 (en) | 1995-09-06 |
| FI96314B (fi) | 1996-02-29 |
| ATE110388T1 (de) | 1994-09-15 |
| JPH0381279A (ja) | 1991-04-05 |
| PT94243A (pt) | 1991-02-08 |
| PT94243B (pt) | 1997-01-31 |
| EP0401049A2 (en) | 1990-12-05 |
| EP0401049A3 (en) | 1991-12-27 |
| DE69011747D1 (de) | 1994-09-29 |
| DK0401049T3 (da) | 1994-09-19 |
| CA2017920A1 (en) | 1990-12-01 |
| EP0401049B1 (en) | 1994-08-24 |
| ES2060042T3 (es) | 1994-11-16 |
| CA2017920C (en) | 1999-07-06 |
| US5132300A (en) | 1992-07-21 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| FI875502A0 (fi) | Morfolinoetylester av mykofenolsyra och dess derivat | |
| NZ275647A (en) | Tricyclic amide and urea derivatives and medicaments | |
| FI102069B (fi) | Menetelmä terapeuttisesti käyttökelpoisten indolijohdannaisten valmist amiseksi | |
| FI906438A (fi) | Menetelmä uusien, terapeuttisesti käyttökelpoisten A-nor-steroidi-3-karboksyylihappojohdannaisten valmistamiseksi | |
| FI883426A0 (fi) | Menetelmä terapeuttisesti käyttökelpoisen pentasakkaridin valmistamiseksi | |
| FI103971B1 (fi) | Menetelmä terapeuttisesti käyttökelpoisten pyrrolo- ja pyrido[2,3-d]pyrimidinonijohdannaisten valmistamiseksi | |
| HUT52511A (en) | Process for producing new substituted cephalosporine-sulfon derivatives and pharmaceutical compositions containing them as active components | |
| ES2055235T3 (es) | Composicion anti-inflamatoria y/o antialergica que comprende derivados de glutation. | |
| FI902725A0 (fi) | Menetelmä terapeuttisesti käyttökelpoisten (7-okso-2,4-ditia-1-atsabisyklo/3,2,0/hept-3-yleenietikkahappojohdannaisten valmistamiseksi | |
| DE3781879D1 (de) | Anthracyclinderivate, verfahren zu ihrer herstellung und ihre verwendung als arzneimittel. | |
| ATE142208T1 (de) | 4,5-dihydro-6h-imidazo(4,5,1-ij>chinolin-6-on-6 oxim-o-sulfonsäurederivate | |
| FI896251A0 (fi) | Menetelmä uusien terapeuttisesti käyttökelpoisten pyratsolopyridiinijohdannaisten valmistamiseksi | |
| NO174962C (no) | Analogifremgangsmåte for fremstilling av terapeutisk aktive 2,5,6,7-tetranor-4,8-inter-m-fenylen PGI2-derivater | |
| ATE146176T1 (de) | Benzo(b)thiophen-3-yl-piperazine, verfahren zur deren herstellung und ihre verwendung als arzneimittel | |
| FI103885B (fi) | Menetelmä terapeuttisesti aktiivisten 1-bentsyyli-4-fenyylipiperatsiinijohdannaisten valmistamiseksi ja välituotteina käyttökelpoisia yhdisteitä | |
| EP0123146A3 (en) | Compounds with antiinflammatory activity, process for preparation thereof and pharmaceutical compositions therefrom | |
| ATE95177T1 (de) | Naphthothiazepin-derivate und verfahren zu ihrer herstellung. | |
| DE69401163D1 (de) | Umwandlungsverfahren von Lorabef Dihydrate in Loracarbef Monohydrate | |
| ES531480A0 (es) | Derivados del acido d-2-(6-metoxi-2-naftil)-propionico | |
| DK1264836T3 (da) | Fremgangsmåde til fremstilling af indolopyrrolocarbaxolderivater |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| BB | Publication of examined application | ||
| FG | Patent granted |
Owner name: PFIZER INC. |